期刊文献+

老年下呼吸道感染患者血清降钙素原检测效果评估 被引量:8

Effect of serum procalcitonin testing on diagnosis of lower respiratory tract infections in elderly patients
原文传递
导出
摘要 目的分析老年下呼吸道细菌性感染患者血清降钙素原(PCT)水平检测的诊断、预后判断价值,为指导临床治疗、评估疗效提供依据。方法选取医院2010年8月-2013年8月收治的371例老年患者,观察其下呼吸道细菌性感染发生情况,并分为感染组及非感染组,按照感染组患者预后分为良好组及较差组,比较各组患者血清PCT水平差异。结果 371例老年患者有69例发生下呼吸道细菌性感染,感染率18.6%;69例患者经治疗后预后良好31例占44.9%,较差38例占55.1%;感染组血清PCT水平显著高于非感染组(P<0.05);预后良好组入院1、8d血清PCT水平均显著低于预后较差组(P<0.05);血清PCT对感染诊断的灵敏度为72.3%、特异度为68.5%,对预后判断的灵敏度为96.4%、特异度为97.0%;相关性分析显示,血清PCT水平与患者APACHEⅡ评分呈显著正相关(r=0.366,P<0.05)。结论血清PCT在老年下呼吸道细菌性感染的诊断和预后判断中均具有良好的指导意义,值得临床广泛推广采用。 OBJECTIVE To analyze the value of serum procalcitonin (PCT) testing in diagnosis of lower respiratory tract bacterial infections in the elderly patients and in evaluation of prognosis so as to provide guidance for clinical treatment and evaluation of effectiveness. METHODS A total of 371 elderly patients who were treated in the hospital from Aug 2010 to Aug 2013 were enrolled in the study, then the incidence of lower respiratory tract bacterial infections was observed, the subjects were divided into the infection group and the non-infection group and divided into the good prognosis group and the poor prognosis groups the serum PCT levels were observed and compared. RESULTS Of the 371 elderly patients, the lower respiratory tract bacterial infections occurred in 69 cases with the infection rate of 18.6%. Among the 69 patients, 31 cases had good prognosis, accounting for 44, 9%, and 38 cases had poor prognosis, accounting for 55.1% ; the serum PCT level of the infection group was significantly higher than that of the noninfection group (P〈0.05). The serum PCT levels at day 1 and 8 admission to the hospital were significantly lower in the good prognosis group than in the poor prognosis group (P〈0.05). The sensitivity of serum PCT in diagnosis of infections was 72.3%, the specificity 68. 5%2 the sensitivity in determination of prognosis was 96.4%, the specificity 97.0%. The correlative analysis indicated that the serum PCT level was positively correlated with APACHE Ⅱ score (r= 0. 366,P〈0.05). CONCLUSION The serum PCT testing has great significance in diagnosis of lower respiratory tract infections in the elderly patients and in determination of prognosis, and it is worthy to be promoted in the clinical practice.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2014年第15期3882-3884,共3页 Chinese Journal of Nosocomiology
基金 国家自然科学基金资助项目(81171586)
关键词 老年 下呼吸道 细菌感染 血清降钙素原 The elderly Lower respiratory tract Bacterial infection Serum procalcitonin
  • 相关文献

参考文献7

  • 1Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract in- fections[J]. Evid Based Child Health, 2013, 8 (4): 1297- 1371.
  • 2Schuetz P, Raad I, Amin DN. Using procalcitonin-guided al- gorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis[J]. Curr Opin Crit Care, 2013,19 (5) : 453-460.
  • 3雷清,代龙文.72例外科感染性疾病降钙素原及C-反应蛋白检测的早期诊断分析[J].检验医学与临床,2009,6(11):842-842. 被引量:16
  • 4Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections[J]. JAMA, 2013, 309 (7) : 717- 718.
  • 5袁园,周新.血清降钙素原在肺部感染中的临床应用[J].临床肺科杂志,2009,14(5):650-651. 被引量:21
  • 6Fazili T, Endy T, Javaid W, et al. Role of procalcitonin in guiding antibiotic therapy[J]. Am J Health Syst Pharm, 2012,69(23) ;2057-2061.
  • 7Gilbert D. Serum proealeitonin levels: comment on "Effec- tiveness and safety of proealeitonin-guided antibiotic therapy in lower respiratory tract infections in real life'[J'L Arch In- tern Med,2012,172(9) :722-723.

二级参考文献18

  • 1王佩芳.下呼吸道感染性疾病中C-反应蛋白测定的临床价值[J].临床和实验医学杂志,2006,5(4):363-364. 被引量:36
  • 2常春,姚婉贞,陈亚红,刘振英,张晓伟.慢性阻塞性肺疾病患者急性加重期血清降钙素原水平的变化及临床意义[J].中华结核和呼吸杂志,2006,29(7):444-447. 被引量:93
  • 3Delevaux I, Andre M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes. Ann Rheum Dis ,2003,62 (4) :337 - 340.
  • 4Jereb M, Kotar T. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia. Wien Klin Wochenschr,2006,118 (5-6) :170 - 174.
  • 5Hirakata Y, Yanagihara K, Kurihara S, et al. Comparison of usefulness of plasma procaleitonin and C-reactive protein measurements for estiroation of severity in adults with community-acquired pneumonia. Diagn Microbiol Infect Dis, 2008,61 ( 2 ) : 170 - 174.
  • 6Christ-Crain M,Stolz D, Bingisser R,et al. Procalcitonin guidance of antibiotic therapy in Communtity-acquired pneumonia:a tandomized trial. Am J Respir Crit Care Med ,2006,174 (1) :84 -93.
  • 7Menendez R, Cavaleanti M, Reyes S, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax,2008, 63(5) :447 -452.
  • 8Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD : a randomized , controlled trial comparing procalcitonin-guidance with standard therapy. Chest,2007,131 ( 1 ) : 9-19.
  • 9Boussekey N, Leroy O, Alfandari S, et al. Procalcitonin kinetics in the prognosis of severe community - acquired pneumonia. Intensive Care Med,2006,32(3) :469 -472.
  • 10Oppert M, Reinicke A, Muller C, et al. Elevations in procaleitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation ,2002,53 (2) : 167 - 170.

共引文献35

同被引文献74

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部